Q1 2022 - February, 2022
Announcement of Quarterly Financial Results
With a focus on the development of small molecule drugs for the treatment of cancer, the goal at ESSA is to develop a pipeline of oncology therapeutics. We will continue to research innovative ideas with the goal of providing a promising future for the patients and community we serve.
With a focus on the development of small molecule drugs for the treatment of cancer, the goal at ESSA is to develop a pipeline of oncology therapeutics. We will continue to research innovative ideas with the goal of providing a promising future for the patients and community we serve.
Q1 2022 - February, 2022
Announcement of Quarterly Financial Results
Investor Contact
Xuan Yang
Solebury Strategic Communications
xyang@soleburystrat.com
Media Contact
Zara Lockshin
Solebury Strategic Communications
zlockshin@soleburystrat.com